BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28784903)

  • 1. Hemophagocytic lymphohistiocytosis with concurrent malarial infection.
    Selvarajan D; Sundaravel S; Alagusundaramoorthy SS; Jacob A
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784903
    [No Abstract]   [Full Text] [Related]  

  • 2. The conundrum of malaria chemoprophylaxis.
    Shanks D
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophagocytic lymphohistiocytosis secondary to Babesia in an immunocompetent adult.
    Kennedy-Snodgrass C; Obayomi M; Muddasani R; Slonim LB; Braunstein M
    Am J Hematol; 2019 Mar; 94(3):379-383. PubMed ID: 30478854
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired haemophagocytic lymphohistiocytosis secondary to multiple myeloma.
    Bhatt R; Xiao S; Gohari P; Podrumar A
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31488450
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 6. Case Report: Hemophagocytic Lymphohistiocytosis Secondary to Plasmodium ovale wallikeri Infection.
    Novella-Mena M; Cantudo-Muñoz P; Tallón-Pérez JD; Gómez-Rodríguez MDM; Rojo-Marcos G
    Am J Trop Med Hyg; 2023 Sep; 109(3):608-610. PubMed ID: 37580024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.
    Radloff PD; Philipps J; Hutchinson D; Kremsner PG
    Trans R Soc Trop Med Hyg; 1996; 90(6):682. PubMed ID: 9015517
    [No Abstract]   [Full Text] [Related]  

  • 8. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
    Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
    Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
    Contentin L; Grammatico-Guillon L; Desoubeaux G; Baron S; Thanh HD
    Presse Med; 2011 Nov; 40(11):1081-3. PubMed ID: 21570798
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone/proguanil.
    Koch S; Göbels K; Richter J; Oette M; Häussinger D
    Parasitol Res; 2007 Mar; 100(4):747-8. PubMed ID: 17004096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
    Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M
    J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercytokinemia with hemophagocytic syndrome due to human metapneumovirus.
    Tamura D; Inoue S; Kawahara Y; Mori M; Yamagata T
    Pediatr Int; 2018 Oct; 60(10):974-976. PubMed ID: 30345702
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemophagocytic lymphohistiocytosis in pregnancy.
    Jawad S; Dhariwal A; Ellis L; Cosgrove C; Reyal Y
    Lancet Haematol; 2020 Jun; 7(6):e498. PubMed ID: 32470441
    [No Abstract]   [Full Text] [Related]  

  • 18. Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them.
    Schwartz E; Lachish T
    Evid Based Med; 2016 Apr; 21(2):64. PubMed ID: 26759150
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
    Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
    J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.